Mirae Asset Global Etfs Holdings Ltd. X4 Pharmaceuticals, Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 63,453 shares of XFOR stock, worth $42,513. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,453Holding current value
$42,513% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XFOR
# of Institutions
107Shares Held
101MCall Options Held
418KPut Options Held
71.7K-
Bain Capital Life Sciences Investors, LLC Boston, MA16.9MShares$11.3 Million2.01% of portfolio
-
Nea Management Company, LLC Timonium, MD15MShares$10 Million0.82% of portfolio
-
Black Rock Inc. New York, NY10.7MShares$7.15 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.29MShares$5.55 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.13MShares$4.78 Million0.1% of portfolio
About X4 Pharmaceuticals, Inc
- Ticker XFOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,646,096
- Market Cap $46M
- Description
- X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...